THEMISMED
Themis Medicare Limited (THEMISMED) Stock Analysis
Themis Medicare Limited is an Indian pharmaceutical company manufacturing APIs and formulations for anti-infectives and other therapies. It operates manufacturing facilities compliant with Indian and international quality standards. The company serves domestic and export markets through generics and contract supply. It is listed on Indian stock exchanges.
Healthcare › Drug Manufacturers - Specialty & Generic
₹108.60
-4.08% 1W | -16.10% 52W
Market Cap
1.0k CR
P/E Ratio
25.1
52W High
₹147
52W Low
₹65
Div. Yield
0.46%
Beta
0.6
50 DMA
₹117.2
200 DMA
₹100.3
Profit Margin
12.1%
Inst. Own.
0%
⚠️ BREAKDOWN
⚠️ BREAKDOWN
Fundamentals
Profit & Loss
| Metric | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 97 | 105 | 83 | 98 | 123 | 117 | 94 | 72 | 98 | 78 | 90 | 77 | 87 |
| Expenses | 75 | 92 | 74 | 89 | 94 | 100 | 88 | 79 | 108 | 81 | 80 | 73 | 139 |
| Operating Profit | 22 | 12 | 8 | 9 | 29 | 17 | 6 | -8 | -10 | -3 | 10 | 4 | -52 |
| OPM % | 22% | 12% | 10% | 10% | 24% | 15% | 6% | -11% | -10% | -4.0% | 11% | 4.9% | -60% |
| Other Income | 6 | 7 | 6 | 5 | 7 | 6 | 1 | 2 | 1 | 5 | 6 | 11 | 97 |
| Interest | 2 | 2 | 3 | 2 | 2 | 2 | 3 | 2 | 2 | 3 | 3 | 3 | 3 |
| Depreciation | 3 | 3 | 3 | 3 | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Profit before tax | 23 | 14 | 8 | 9 | 31 | 18 | 2 | -11 | -14 | -3 | 10 | 9 | 39 |
| Tax % | 19% | 19% | 10% | 24% | 21% | 20% | 69% | -13% | 1% | 5% | 3% | 2% | 36% |
| Net Profit | 18 | 11 | 7 | 7 | 25 | 14 | 1 | -10 | -14 | -4 | 10 | 9 | 25 |
| EPS in Rs | 1.98 | 1.23 | 0.80 | 0.72 | 2.68 | 1.55 | 0.06 | -1.05 | -1.54 | -0.39 | 1.10 | 0.97 | 2.67 |
| Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 202 | 232 | 217 | 210 | 184 | 202 | 231 | 395 | 354 | 382 | 406 | 342 | 332 |
| Expenses | 184 | 194 | 184 | 184 | 181 | 166 | 181 | 299 | 287 | 330 | 356 | 342 | 374 |
| Operating Profit | 18 | 38 | 33 | 25 | 2 | 36 | 49 | 96 | 67 | 52 | 49 | 0 | -42 |
| OPM % | 9% | 16% | 15% | 12% | 1.2% | 18% | 21% | 24% | 19% | 13% | 12% | 0.1% | -13% |
| Other Income | 13 | 3 | 4 | 6 | 5 | 12 | 13 | 18 | 25 | 24 | 11 | 23 | 118 |
| Interest | 15 | 12 | 12 | 12 | 12 | 13 | 13 | 9 | 10 | 9 | 10 | 11 | 11 |
| Depreciation | 11 | 12 | 7 | 7 | 8 | 8 | 9 | 9 | 10 | 12 | 10 | 10 | 10 |
| Profit before tax | 5 | 17 | 18 | 11 | -13 | 27 | 41 | 95 | 73 | 53 | 40 | 2 | 55 |
| Tax % | -20% | 11% | 9% | 1% | -15% | 8% | 14% | 23% | 22% | 19% | 25% | 40% | |
| Net Profit | 6 | 16 | 16 | 11 | -11 | 25 | 36 | 73 | 57 | 44 | 30 | 1 | 40 |
| EPS in Rs | 0.73 | 1.91 | 1.77 | 1.23 | -1.17 | 2.70 | 3.88 | 7.92 | 6.18 | 4.73 | 3.24 | 0.12 | 4.35 |
| Dividend Payout % | 25% | 9% | 0% | 0% | 0% | 6% | 11% | 6% | 8% | 11% | 15% | 404% |
Growth — CAGR
| Metric | 3Y | 5Y | 10Y |
|---|---|---|---|
| Revenue CAGR | -1.0% | 8.0% | 4.0% |
| Profit CAGR | -69.0% | -46.0% | -20.0% |
Shareholding Pattern
Promoters67.15%
FIIs0.09%
DIIs0.01%
Public32.75%
Promoters67.15%
FIIs0.06%
DIIs0.01%
Public32.77%
Promoters67.10%
FIIs0.05%
DIIs0.01%
Public32.84%
Promoters67.10%
FIIs0.11%
DIIs0.01%
Public32.78%
Promoters67.10%
FIIs0.01%
DIIs0.01%
Public32.87%
Promoters67.16%
FIIs0.06%
DIIs0.01%
Public32.78%
Promoters67.15%
FIIs0.03%
DIIs0.01%
Public32.81%
Promoters67.15%
FIIs0.14%
DIIs0.01%
Public32.70%
Promoters67.10%
FIIs0.11%
DIIs0.01%
Public32.78%
Promoters67.10%
FIIs0.01%
DIIs0.01%
Public32.87%
THEMISMED
Holdings Analysis
Key strengths & risk signals
53
Overall
37
Fundamental
69
Technical
Risks (4)
Cannot calculate PEG - insufficient growth data.
RECOVERY MODE! Current price (108.6) above 200-day but below 50-day.
WEAK YEAR! Stock declined 16.1% in the last year.
NEGATIVE MOMENTUM! Price declined across timeframes - down 4.1% (1 week), 18.2% (1 month), 7.2% (3 months).
Strengths (3)
BULLISH TREND! 50-day average (117.2) is above 200-day average (100.3) - positive signal.
BULLISH SENTIMENT! In last 30 days: 9 up days, 21 down days. Avg volume on up days: 621,170 vs down days: 124,734. Ratio: 4.98x
LOW VOLATILITY! Beta of 0.60 - stable stock, less market risk.
Fundamental & Technical Analysis
53Overall
37Fundamental
69Technical
Fundamental Breakdown
Growth Quality
4/30
Revenue CAGR: -0.4% (DECLINING, 2/15). Profit CAGR: -72.8% (DECLINING, 2/15).
Profit Margin
5/10
DECENT EFFICIENCY! 12.1% profit margin - acceptable profitability.
PEG Valuation
1/10
Cannot calculate PEG - insufficient growth data.
Dividend Yield
3/10
NEGLIGIBLE DIVIDEND! 0.46% yield - little to no income.
Debt to Equity
10/10
VERY LOW DEBT! D/E of 0.00 - excellent financial health.
Public Holding
10/20
SIGNIFICANT PUBLIC HOLDING! 32.8% public ownership - moderate retail influence.
Stability Index
4/10
CAREFUL! Company does not have stable profit track. 2 loss-making quarters detected.
Technical Breakdown
Moving Averages
12/10
BULLISH TREND! 50-day average (117.2) is above 200-day average (100.3) - positive signal.
Price Position
2/10
RECOVERY MODE! Current price (108.6) above 200-day but below 50-day.
Trend Pattern
10/20
BREAKDOWN! Stock has broken below support levels - weakness present.
52W Performance
2/10
WEAK YEAR! Stock declined 16.1% in the last year.
Volume Sentiment
30/30
BULLISH SENTIMENT! In last 30 days: 9 up days, 21 down days. Avg volume on up days: 621,170 vs down days: 124,734. Ratio: 4.98x
RSI
4/5
APPROACHING OVERSOLD! RSI at 36.1 - watch for reversal.
52W Range
3/5
MID RANGE! Trading at 53.2% of 52W range - neutral zone.
Momentum
1/5
NEGATIVE MOMENTUM! Price declined across timeframes - down 4.1% (1 week), 18.2% (1 month), 7.2% (3 months).
Beta
5/5
LOW VOLATILITY! Beta of 0.60 - stable stock, less market risk.
Peer Comparison
Healthcare · Drug Manufacturers - Specialty & Generic · 8 stocks
| Stock | Price | P/E | Profit Margin | Revenue CAGR 5Y | Profit CAGR 5Y | 52W Change | Stock Strength | Trendline | YoY Profit | QoQ Profit | YoY Revenue | QoQ Revenue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| THEMISMED | ₹108.60 | 25.1 | 12.1% | -0.4% | -72.8% | -16.1% | 53 | BREAKDOWN | -273.2% | +176.4% | -10.9% | +13.7% |
| BAFNAPH | ₹418.00 | 127.1 | 5.5% | 9.3% | -0.7% | +152.4% | 66 | BREAKOUT | -97.1% | -96.3% | -23.1% | -37.0% |
| LINCOLN | ₹558.30 | 11.6 | 13.9% | 9.5% | 6.4% | +6.6% | 57 | BREAKDOWN | +30.7% | +212.1% | +15.1% | -5.3% |
| SIGACHI | ₹28.50 | 42.6 | 5.4% | 16.5% | – | -24.4% | 56 | BREAKDOWN | -106.8% | -11.7% | -5.4% | -0.5% |
| BAJAJHCARE | ₹320.00 | 46.2 | 2.8% | -1.8% | -28.4% | -32.8% | 44 | BOUNCE FROM SUPPORT | +16.1% | -159.8% | +11.3% | +8.2% |
| KILITCH | ₹241.60 | 27.4 | 12.7% | 19.2% | 42.4% | +41.9% | 84 | BREAKOUT | -3.3% | -80.0% | +4.2% | -49.9% |
| ANUHPHR | ₹82.00 | 18.6 | 5.7% | 13.5% | 4.3% | +4.0% | 64 | BREAKDOWN | +37.3% | -2.6% | +3.9% | -4.1% |
| ZIMLAB | ₹150.50 | 183.5 | 0.9% | -2.5% | -37.9% | +105.9% | 57 | APPROACHING RESISTANCE | +110.5% | -208.1% | +31.2% | -10.5% |
Data from TradeAlone · Updated daily
